Showing results (471-480 of 656) with videos related to

Sort By:
Pageof 66
Journal of the American College of Cardiology|October 2, 2007
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trialMarie-Claude Morice, Patrick W Serruys, Paul Barragan, et al.
Circulation|September 13, 2017
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)Pierre Deharo, Gregory Ducrocq, Christoph Bode, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2002
Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulationNiels van Royen, Imo Hoefer, Ivo Buschmann, et al.
Heart Rhythm|May 9, 2017
Phase-contrast magnet resonance imaging reveals regional, transmural, and base-to-apex dispersion of mechanical dysfunction in patients with long QT syndromeJohannes Brado, Markus J Dechant, Marius Menza, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 16, 2014
"Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI - a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT)Klaus Kaier, Anja Gutmann, Werner Vach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 2012
ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesionJolanta M Siller-Matula, Yahye Merhi, Jean-François Tanguay, et al.
Blood Vessels, Thrombosis & Hemostasis|January 23, 2026
A transgenic mouse model for reticulated platelet detection reveals expansion after myocardial ischemia/reperfusionMuataz Ali Hamad, Nancy Schanze, Krystin Krauel, et al.
European Heart Journal|November 27, 2025
Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failureNicolas Schommer, Nicolas Gendron, Krystin Krauel, et al.
Circulation|June 23, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.
JAMA Cardiology|February 4, 2026
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.
Pageof 66